National Bank of Canada FI Has $44.06 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

National Bank of Canada FI increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 85.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,628,200 shares of the medical instruments supplier's stock after acquiring an additional 751,800 shares during the period. National Bank of Canada FI owned about 0.82% of DENTSPLY SIRONA worth $44,059,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. UMB Bank n.a. boosted its stake in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after buying an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA during the third quarter valued at $27,000. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares in the last quarter. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA in the 3rd quarter worth about $35,000. Finally, Rothschild Investment LLC purchased a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth about $32,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently commented on XRAY shares. Mizuho started coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price target for the company. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research note on Friday, November 8th. Finally, UBS Group lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $28.40.

DENTSPLY SIRONA Stock Performance

XRAY stock traded up $0.37 during trading on Monday, reaching $19.45. 2,390,961 shares of the stock were exchanged, compared to its average volume of 3,094,770. The stock has a 50 day simple moving average of $21.71 and a 200-day simple moving average of $24.38. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.87 billion, a P/E ratio of -9.40, a price-to-earnings-growth ratio of 1.87 and a beta of 0.97. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analysts' expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. During the same period last year, the business earned $0.49 earnings per share. DENTSPLY SIRONA's quarterly revenue was up .4% compared to the same quarter last year. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.